{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:49:39Z","timestamp":1792050579200,"version":"4.4.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008481","name":"Association of Canadian Universities for Research in Astronomy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008481","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019211","name":"AbbVie Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019211","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008467","name":"Canadian Association of Radiation Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008467","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022179","name":"Prostate Cancer Fight Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022179","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.prro.2022.05.018","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T03:42:53Z","timestamp":1655437373000},"page":"e531-e537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["A Prospective Study of Magnetic Resonance Imaging-guided Focal Salvage High-dose-Rate Brachytherapy for Radiorecurrent Prostate Cancer: Updated Results of 30 Patients"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2567-2746","authenticated-orcid":false,"given":"Mark T.","family":"Corkum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Andrew","family":"Loblaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Lin","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jure","family":"Murgic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananth","family":"Ravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie T.M.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Wronski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoom","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans T.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2022.05.018_bib0001","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.juro.2015.06.100","article-title":"Anatomical patterns of recurrence following biochemical relapse in the dose escalation era of external beam radiotherapy for prostate cancer","volume":"194","author":"Zumsteg","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.prro.2022.05.018_bib0002","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ijrobp.2019.11.001","article-title":"A prospective study of 18F-DCFPyL PSMA PET\/CT restaging in recurrent prostate cancer following primary external beam radiotherapy or brachytherapy","volume":"106","author":"Liu","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.05.018_bib0003","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000481438","article-title":"Management of biochemical recurrence after primary curative treatment for prostate cancer: A review","volume":"100","author":"Artibani","year":"2018","journal-title":"Urol Int"},{"key":"10.1016\/j.prro.2022.05.018_bib0004","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1002\/cncr.24283","article-title":"Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer","volume":"115","author":"Taylor","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2022.05.018_bib0005","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.eururo.2020.11.010","article-title":"A systematic review and meta-analysis of local salvage therapies after radiotherapy for prostate cancer (MASTER)","volume":"80","author":"Valle","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.prro.2022.05.018_bib0006","first-page":"701","article-title":"Underutilization of local salvage therapy after radiation therapy for prostate cancer","volume":"32","author":"Tran","year":"2014","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"10.1016\/j.prro.2022.05.018_bib0007","article-title":"Utilization of salvage and systemic therapies for recurrent prostate cancer as a result of 18F-DCFPyL PET\/CT restaging","volume":"6","author":"Liu","year":"2020","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.prro.2022.05.018_bib0008","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.adro.2020.04.022","article-title":"A novel salvage option for local failure in prostate cancer, reirradiation using external beam or stereotactic radiation therapy: Systematic review and meta-analysis","volume":"5","author":"Corkum","year":"2020","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.prro.2022.05.018_bib0009","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ijrobp.2018.06.039","article-title":"Focal Salvage High Dose-Rate Brachytherapy for Locally Recurrent Prostate Cancer After Primary Radiation Therapy Failure: Results From a Prospective Clinical Trial","volume":"102","author":"Murgic","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.05.018_bib0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.brachy.2018.08.006","article-title":"Clinical evaluation of an MRI-to-ultrasound deformable image registration algorithm for prostate brachytherapy","volume":"18","author":"Shaaer","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.prro.2022.05.018_bib0011","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.clon.2019.10.008","article-title":"Single-dose focal salvage high dose rate brachytherapy for locally recurrent prostate cancer","volume":"32","author":"Chitmanee","year":"2020","journal-title":"Clin Oncol"},{"key":"10.1016\/j.prro.2022.05.018_bib0012","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijrobp.2020.01.023","article-title":"MRI-guided ultrafocal salvage high-dose-rate brachytherapy for localized radiorecurrent prostate cancer: Updated results of 50 patients","volume":"107","author":"van Son","year":"2020","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.prro.2022.05.018_bib0013","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brachy.2013.11.005","article-title":"A phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy","volume":"13","author":"Yamada","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.prro.2022.05.018_bib0014","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ijrobp.2021.10.138","article-title":"Salvage low-dose-rate prostate brachytherapy: Clinical outcomes of a phase 2 trial for local recurrence after external beam radiation therapy (NRG Oncology\/RTOG 0526)","volume":"112","author":"Crook","year":"2022","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.prro.2022.05.018_bib0015","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/cncr.22934","article-title":"Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable-risk prostate cancer","volume":"110","author":"Nguyen","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2022.05.018_bib0016","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.canrad.2014.07.153","article-title":"Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: Who, when, where and how?","volume":"18","author":"Cr\u00e9hange","year":"2014","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.prro.2022.05.018_bib0017","first-page":"41","article-title":"Defining radio-recurrent intra-prostatic target volumes using PSMA-targeted PET\/CT and multi-parametric MRI","volume":"32","author":"Liu","year":"2022","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.prro.2022.05.018_bib0018","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.eururo.2017.08.005","article-title":"Topography of prostate cancer recurrence after radiation therapy: A detailed mapping study of salvage radical prostatectomy specimens","volume":"73","author":"Takeda","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.prro.2022.05.018_bib0019","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.radonc.2020.07.036","article-title":"Is prostate brachytherapy a dying art? Trends and variation in the definitive management of prostate cancer in Ontario","volume":"152","author":"Corkum","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2022.05.018_bib0020","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/JU.0000000000002187","article-title":"Radiation oncologist consultations prior to radical prostatectomy: Disparities and opportunities","volume":"207","author":"Corkum","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.prro.2022.05.018_bib0021","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.radonc.2020.12.021","article-title":"Prostate high dose-rate brachytherapy as monotherapy for prostate cancer: Late toxicity and patient reported outcomes from a randomized phase II clinical trial","volume":"156","author":"Corkum","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2022.05.018_bib0022","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.radonc.2020.02.009","article-title":"Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy","volume":"146","author":"Morton","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2022.05.018_bib0023","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.clon.2021.12.006","article-title":"Ultrahypofractionated radiotherapy for localised prostate cancer: How far can we go?","volume":"34","author":"Corkum","year":"2022","journal-title":"Clin Oncol"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850022001989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850022001989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:25:18Z","timestamp":1761819918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850022001989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1879850022001989"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2022.05.018","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Prospective Study of Magnetic Resonance Imaging-guided Focal Salvage High-dose-Rate Brachytherapy for Radiorecurrent Prostate Cancer: Updated Results of 30 Patients","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2022.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}